PNC Financial Services Group
ARCT icon

PNC Financial Services Group’s Arcturus Therapeutics ARCT Stock Holding History

PNC Financial Services Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.8K Buy
2,247
+1,202
+115% +$12.6K ﹤0.01% 3646
2026
Q2 		$7.02K Sell
1,045
-13
-1% -$102 ﹤0.01% 4254
2026
Q1 		$8.17K Buy
1,058
+439
+71% +$3.2K ﹤0.01% 4042
2025
Q4 		$3.79K Buy
619
+481
+349% +$5.2K ﹤0.01% 4337
2025
Q3 		$2.54K Hold
138
– – ﹤0.01% 4437
2025
Q2 		$1.8K Buy
138
+85
+160% +$1K ﹤0.01% 4440
2025
Q1 		$561 Buy
53
+45
+563% +$714 ﹤0.01% 4616
2024
Q4 		$136 Hold
8
– – ﹤0.01% 4691
2024
Q3 		$186 Hold
8
– – ﹤0.01% 4685
2024
Q2 		$195 Sell
8
-12
-60% -$364 ﹤0.01% 4671
2024
Q1 		$675 Buy
+20
New +$709 ﹤0.01% 4445
2014
Q3 		– Sell
-143
Closed -$17K – 3974
2014
Q2 		$17K Hold
143
– – ﹤0.01% 2980
2014
Q1 		$18K Buy
+143
New +$21.2K ﹤0.01% 2873

Other funds holding ARCT

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

PNC Financial Services Group's ARCT Position: Q3 2026 in Review

PNC Financial Services Group increased its Arcturus Therapeutics (ARCT) stake by 115% in Q3 2026, buying an estimated $12.6K and bringing the position to 2,247 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3646.

PNC Financial Services Group first reported a position in ARCT in Q1 2014 and has held it in 13 quarters since. 113 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • PNC Financial Services Group held 2,247 shares of Arcturus Therapeutics worth $30.8K as of Q3 2026.
  • PNC Financial Services Group bought 1,202 Arcturus Therapeutics shares in Q3 2026, an estimated $12.6K.
  • Arcturus Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3646 holding.
  • PNC Financial Services Group first reported a position in Arcturus Therapeutics in Q1 2014 and has held it in 13 quarters since.
  • 113 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.